Is Byetta FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Byetta is FDA approved and how it is commonly categorized.
Overview
Byetta is the brand name for exenatide, a twice-daily injectable GLP-1 receptor agonist used to help improve blood sugar control in adults with type 2 diabetes.
FDA Status Details
Byetta is classified as FDA Approved. It was approved by the FDA as a prescription medication for improving glycemic control in adults with type 2 diabetes when used alongside diet and exercise.
Approved Use
Byetta is approved for blood sugar management in adults with type 2 diabetes. It is not approved as a primary weight-loss medication, although weight reduction may occur during treatment.
Brand & Prescription Status
Byetta is an FDA-approved branded prescription medication and should be distinguished from compounded GLP-1 products or research-only peptide products marketed online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.